GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (OTCPK:SBLOF) » Definitions » Market Cap

Shin Nippon Biomedical Laboratories (Shin Nippon Biomedical Laboratories) Market Cap : $369.5 Mil (As of Jun. 08, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shin Nippon Biomedical Laboratories's share price for the quarter that ended in Dec. 2023 was $16.97. Shin Nippon Biomedical Laboratories's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 41.6 Mil. Therefore, Shin Nippon Biomedical Laboratories's market cap for the quarter that ended in Dec. 2023 was $706.5 Mil.

Shin Nippon Biomedical Laboratories's quarterly market cap stayed the same from Jun. 2023 ($706.5 Mil) to Sep. 2023 ($706.5 Mil) and stayed the same from Sep. 2023 ($706.5 Mil) to Dec. 2023 ($706.5 Mil).

Shin Nippon Biomedical Laboratories's annual market cap stayed the same from Mar. 2022 ($0.0 Mil) to Mar. 2023 ($0.0 Mil) but then increased from Mar. 2023 ($0.0 Mil) to Mar. 2024 ($706.5 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shin Nippon Biomedical Laboratories's Enterprise Value for Today is $469.5 Mil.


Shin Nippon Biomedical Laboratories Market Cap Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories Market Cap Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 706.49

Shin Nippon Biomedical Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 706.49 706.49 706.49 706.49

Competitive Comparison of Shin Nippon Biomedical Laboratories's Market Cap

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Market Cap distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Market Cap falls into.



Shin Nippon Biomedical Laboratories Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Shin Nippon Biomedical Laboratories's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=$16.97*41.6319
=$706.5

Shin Nippon Biomedical Laboratories's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=$16.97*41.6319
=$706.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shin Nippon Biomedical Laboratories  (OTCPK:SBLOF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Shin Nippon Biomedical Laboratories Market Cap Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Shin Nippon Biomedical Laboratories (Shin Nippon Biomedical Laboratories) Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (Shin Nippon Biomedical Laboratories) Headlines